How will the COVID-19 variants impact vaccine efficacy? Join our panel of experts from the Texas A&M Univeristy Bush School of Government & Public Service Scowcroft Institute of International Affairs and the Division of Research, Emergency Management Advisory Group and College of Veterinary Medicine & Biomedical Sciences as they discuss COVID-19 vaccines and variants.
This panel, A Race Against Time? COVID-19 Vaccines and SARS CoV2 Variants, will take place via Zoom on April 22, 2021, at 5 p.m. The event is open to the public and registration is required to receive the Zoom link. Register online to attend at bush.tamu.edu/scowcroft/events.
The panel will address questions such as: How well do the current vaccines protect against new SARS-CoV2 Variants? How quickly can Texas, the U.S. and the globe reach herd immunity? Does the global vaccine industry have the needed manufacturing capacity? What’s the likelihood that variants will become increasingly resistant to vaccines?
Panelists include Alan D. T. Barrett, PhD, Director of the Sealy Institute for Vaccine Sciences at the University of Texas Medical Branch, Galveston, Texas; Mahesh Kumar, PhD, Senior Vice President of Global Biologics R&D, Zoetis, Inc.; Benjamin Neuman, PhD, Professor of Biology and Chief Virologist of the Global Health Research Complex at Texas A&M University; and Jennifer Shuford, MD, MPH, Chief State Epidemiologist at the Texas Department of State Health Services.
An introduction will be given by Gerald W. Parker, Jr., DVM, PhD, Associate Dean for Global One Health at the Texas A&M College of Veterinary & Biomedical Sciences. The panel will be moderated by Allison Ficht, PhD, Senior Associate Vice President for Research, Regent’s Professor and Director of the Center for Microencapsulation and Drug Delivery at Texas A&M College of Medicine.
